Pharma stocks Laurus, Gland, Divi's, Piramal rally up to 89%
In short
Laurus Labs, Gland Pharma, Divi’s Laboratories and Piramal Pharma all climbed over the past six months. Laurus Labs rose 88.64%, Gland Pharma 80.36%, Divi’s Laboratories 72.35% and Piramal Pharma 38.65%.
Investors were upbeat on quarterly results and CDMO stocks. That helped push these pharma names much higher.
What the reporting says
Laurus Labs, Gland Pharma, Divi’s Laboratories and Piramal Pharma rose sharply over the past six months, with Laurus Labs gaining 88.64%, Gland Pharma 80.36%, Divi’s Laboratories 72.35% and Piramal Pharma 38.65%. The move came as market optimism built around quarterly results and broader strength in CDMO names. The rally lifted these drug manufacturing stocks into one of the strongest runs in the sector.
Why it matters
Laurus Labs, Gland Pharma, Divi’s Laboratories and Piramal Pharma gained over six months as investors turned more positive on pharma names tied to contract development and manufacturing. The reported gains were led by Laurus Labs at 88.64%, followed by Gland Pharma, Divi’s Laboratories and Piramal Pharma. The market move reflects expectations around upcoming quarterly numbers and sentiment toward the sector.